Abstract
Inoculation of rodents with varicella-zoster virus (VZV) results in a latent infection in dorsal root ganglia with expression of at least five of the six VZV transcripts and one of the viral proteins that are reported to be expressed during latency in human ganglia. Rats develop allodynia and hyperalgesia in the limb distal to the site of injection and the resulting exaggerated withdrawal response to stimuli is reduced by treatment with gabapentin and amitryptyline, but not by antiviral therapy. Inoculation of rats with VZV mutants show that most viral genes are dispensable for latency, but that some genes (e.g., ORF4, 29, and ORF63) that are expressed during latency are important for the establishment of latency in rodents, but not for infection of rodent ganglia. The rodent model for VZV latency allows one to study ganglia removed immediately after death, avoiding the possibility of reactivation, and helps to identify VZV genes required for latency.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- VZV:
-
Varicella-zoster virus
- HSV:
-
Herpes simplex virus
References
Ambagala AP, Cohen JI (2007) Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response. J Virol 81:7844–7851
Annunziato P, LaRussa P, Lee P, Steinberg S, Lungu O, Gershon AA, Silverstein S (1998) Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J Infect Dis 178(Suppl 1):S48–S51
Brunell PA, Ren LC, Cohen JI, Straus SE (1999) Viral gene expression in rat trigeminal ganglia following neonatal infection with varicella-zoster virus. J Med Virol 58:286–290
Cohen JI, Nguyen H (1998) Varicella-zoster virus ORF61 deletion mutants replicate in cell culture, but a mutant with stop codons in ORF61 reverts to wild-type virus. Virology 246:306–316
Cohen JI, Seidel KE (1993) Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci USA 90:7376–7380
Cohen JI, Seidel KE (1994) Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J Virol 68:7850–7858
Cohen JI, Seidel KE (1995) Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 206:835–842
Cohen JI, Wang Y, Nussenblatt R, Straus SE, Hooks JJ (1998) Chronic uveitis in guinea pigs infected with varicella-zoster virus expressing Escherichia coli beta-galactosidase. J Infect Dis 177:293–300
Cohen JI, Cox E, Pesnicak L, Srinivas S, Krogmann T (2004) The varicella-zoster virus ORF63 latency-associated protein is critical for establishment of latency. J Virol 78:11833–11834
Cohen JI, Krogmann T, Bontems S, Sadzot C, Pesnicak L (2005a) Regions of the varicella-zoster virus ORF63 latency-associated protein important for efficient replication in vitro are also critical for efficient establishment of latency. J Virol 79:5069–5077
Cohen JI, Krogmann T, Ross JP, Pesnicak LP, Prikhod’ko EA (2005b) The varicella-zoster virus ORF4 latency associated protein is important for establishment of latency. J Virol 79:6969–6975
Cohen JI, Krogmann T, Pesnicak L, Ali MA (2007) Absence or overexpression of the varicella-zoster virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces latency in a rodent model. J Virol 81:1586–1591
Cohrs RJ, Gilden DH, Kinchington PR, Grinfeld E, Kennedy PG (2003) Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia. J Virol 77:6660–6665
Cox E, Reddy S, Iofin I, Cohen J (1998) Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for replication in cell culture. Virology 250:205–209
Dalziel RG, Bingham S, Sutton D, Grant D, Champion JM, Dennis SA, Quinn JP, Bountra C, Mark MA (2004) Allodynia in rats infected with varicella zoster virus–a small animal model for post-herpetic neuralgia. Brain Res Brain Res Rev 46:234–242
Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B (1995) Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 69:3240–3245
Fleetwood-Walker SM, Quinn JP, Wallace C, Blackburn-Munro G, Kelly BG, Fiskerstrand CE, Nash AA, Dalziel RG (1999) Behavioural changes in the rat following infection with varicella-zoster virus. J Gen Virol 80:2433–2436
Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM (2005) Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118:97–111
Grinfeld E, Kennedy PG (2004) Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes 29:317–319
Grinfeld E, Sadzot-Delvaux C, Kennedy PG (2004) Varicella-zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model. Virology 323:85–90
Grinfeld E, Goodwin R, Kennedy PG (2007) Varicella-Zoster virus gene expression at variable periods following death in a rat model of ganglionic infection. Virus Genes 35:29–32
Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS (2007) Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 144:1495–1508
Heineman TC, Cohen JI (1995) The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J Virol 69:7367–7370
Heineman TC, Seidel K, Cohen JI (1996) The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J Virol 70:7312–7317
Hoover SE, Cohrs RJ, Rangel ZG, Gilden DH, Munson P, Cohen JI (2006) Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency. J Virol 80:3459–3468
Kennedy PG, Grinfeld E, Bell JE (2000) Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol 74:11893–11898
Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C (2001) Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289:218–223
Leib DA, Bogard CL, Kosz-Vnenchak M, Hicks KA, Coen DM, Knipe DM, Schaffer PA (1989) A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol 63:2893–2900
Li Q, Ali MA, Cohen JI (2006) Insulin degrading enzyme is a cellular receptor for varicella-zoster virus infection and for cell-to-cell spread of virus. Cell 127:305–316
Lungu O, Panagiotidis CA, Annunziato PW, Gershon AA, Silverstein SJ (1998) Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency. Proc Natl Acad Sci USA 95:7080–7085
Mahalingam R, Wellish M, Cohrs R, Debrus S, Piette J, Rentier B, Gilden DH (1996) Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci USA 93:2122–2124
Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D (1990) Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 323:627–631
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP (2008) Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain. Pain 138:61–69
Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM (1998) Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72:965–974
Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM (1999) The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci USA 95:11969–11974
Moffat J, Ito H, Sommer M, Taylor S, Arvin AM (2002) Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol 76:8468–8471
Oliver SL, Zerboni L, Sommer M, Rajamani J, Arvin AM (2008) Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. J Virol Methods 154:182–193
Reddy SM, Cox E, Iofin I, Soong W, Cohen JI (1998) Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranscriptionally modified by the VZV ORF47 protein kinase. J Virol 72:8083–8088
Sadzot-Delvaux C, Merville-Louis MP, Delrée P, Marc P, Piette J, Moonen G, Rentier B (1990) An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res 26:83–89
Sadzot-Delvaux C, Debrus S, Nikkels A, Piette J, Rentier B (1995) Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology 45(12 Suppl 8):S18–S20
Sato H, Callanan LD, Pesnicak L, Krogmann T, Cohen JI (2002a) Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37°C, but not 33°C. J Virol 76:11012–11023
Sato H, Pesnicak L, Cohen JI (2002b) Varicella-zoster virus ORF2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J Virol 76:3575–3578
Sato H, Pesnicak L, Cohen JI (2003a) Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency. J Med Virol 70:S79–S81
Sato H, Pesnicak L, Cohen JI (2003b) Varicella-zoster Virus ORF47 protein kinase which is required for replication in human T cells, and ORF66 protein kinase which is expressed during latency, are dispensable for establishment of latency. J Virol 77:11180–11185
Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI (2000) Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 74:1864–1870
Strelow LI, Leib DA (1995) Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J Virol 69:6779–6786
Tal-Singer R, Pichyangkura R, Chung E, Lasner TM, Randazzo BP, Trojanowski JQ, Fraser NW, Triezenberg SJ (1999) The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology 259:20–23
Thompson RL, Sawtell NM (2001) Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol 75:6660–6675
Wallace VC, Segerdahl AR, Lambert DM, Vandevoorde S, Blackbeard J, Pheby T, Hasnie F, Rice AS (2007) The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy. Br J Pharmacol 151:1117–1128
Wroblewska Z, Valyi-Nagy T, Otte J, Dillner A, Jackson A, Sole DP, Fraser NW (1993) A mouse model for varicella-zoster virus latency. Microb Pathog 15:141–151
Xia D, Srinivas S, Sato H, Pesnicak L, Straus SE, Cohen JI (2003) Varicella-zoster virus ORF21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J Virol 77:1211–1218
Zerboni L, Sommer M, Ware CF, Arvin AM (2000) Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology 270:278–285
Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H (2007) Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81:9024–9033
Acknowledgement
I thank the intramural research program of the National Institute of Allergy and Infectious Diseases for support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cohen, J.I. (2010). Rodent Models of Varicella-Zoster Virus Neurotropism. In: Abendroth, A., Arvin, A., Moffat, J. (eds) Varicella-zoster Virus. Current Topics in Microbiology and Immunology, vol 342. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2010_11
Download citation
DOI: https://doi.org/10.1007/82_2010_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12727-4
Online ISBN: 978-3-642-12728-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)